FDA’s advisers back plan to simplify COVID-19 vaccinations

The United States is poised to make COVID-19 vaccinations more like a yearly flu shot, a major shift in strategy despite a long list of questions about how to best protect against a still rapidly mutating virus.

The Food and Drug Administration asked its scientific advisers Thursday to help lay the groundwork for switching to once-a-year boosters for most Americans -- and how and when to periodically update the shots' recipe.

“This is a consequential meeting to determine if we've reached the point in the pandemic that allows for simplifying the use of current COVID-19 vaccines,” said FDA's Dr David Kaslow.

The advisory panel mostly agreed with the FDA's approach.

COVID-19 vaccines have saved millions of lives and booster doses continue to help the most vulnerable even as more contagious variants have popped up.

But protection does wane and the shots don't fend off milder infections for long.

And people are tired of getting vaccinated. While more than 80% of the US population has had at least one COVID-19 shot, only 16% of those eligible for the latest boosters -- so-called bivalent doses updated to better match more recent virus strains -- have gotten one.

That makes for tough decisions on how to move forward: Who really needs another shot, how often and what kind?

“We're still protected against severe disease, thank goodness,” even after the latest mutated omicron strains cropped up, noted FDA adviser Dr Paul Offit, a vaccine expert at Children's Hospital of Philadelphia.

Follow The Gleaner on Twitter and Instagram @JamaicaGleaner and on Facebook @GleanerJamaica. Send us a message on WhatsApp at 1-876-499-0169 or email us at onlinefeedback@gleanerjm.com or editors@gleanerjm.com.